Sorrento Therapeutics Inc
NASDAQ:SRNE
Sorrento Therapeutics Inc
Equity Earnings Affiliates
Sorrento Therapeutics Inc
Equity Earnings Affiliates Peer Comparison
Competitive Equity Earnings Affiliates Analysis
Latest Figures & CAGR of Competitors
Company | Equity Earnings Affiliates | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sorrento Therapeutics Inc
NASDAQ:SRNE
|
Equity Earnings Affiliates
-$18.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Equity Earnings Affiliates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Equity Earnings Affiliates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Equity Earnings Affiliates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Equity Earnings Affiliates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Equity Earnings Affiliates
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Sorrento Therapeutics Inc's Equity Earnings Affiliates?
Equity Earnings Affiliates
-18.4m
USD
Based on the financial report for Dec 31, 2022, Sorrento Therapeutics Inc's Equity Earnings Affiliates amounts to -18.4m USD.
What is Sorrento Therapeutics Inc's Equity Earnings Affiliates growth rate?
Equity Earnings Affiliates CAGR 1Y
-14 524%
Over the last year, the Equity Earnings Affiliates growth was -14 524%.